Photo credit martha farmer linked in page

Photo credit martha farmer linked in page

Martha Farmer, PhD

Dr. Martha Farmer is retired president & CEO, co-founder and current board member of North Shore InnoVentures (NSIV), a technology incubator for innovative start-ups in life science and cleantech. NSIV was awarded a ten-year Sustaining Grant by the Cummings Foundation. The International Business Innovation Association (InBIA) awarded NSIV the Dinah Atkins Technology Incubator of the Year in April of 2018 for their work accelerating the growth of startups through access to well-equipped labs, mentoring, sponsored services and networking to capital. Their portfolio of 44 startups has raised more than $250M and created 300 good jobs.

Martha is a member of the Board of Directors of NSIV and a mentor for several of the startups. She also is on the Board of the North Shore Technology Council and the Life Sciences Consortium of the North Shore, a consortium of local colleges created to insure students are well prepared for careers in our industry. She is serving as an advisor/consultant to startups, colleges and incubators. Dr. Farmer is dedicated to making an impact through fostering innovation and entrepreneurship. Martha earned her BS in Zoology and her PhD in Physiology and Pharmacology from Duke University. She completed her postdoctoral fellowship at the Johns Hopkins University.

Steve Munk.jpg

Stephen Munk, PhD

Dr. Munk is experienced in drug discovery, development, and manufacturing both as a scientist and as a manager. He was the CEO and President of Ash Stevens Inc., a full service Active Pharmaceutical Ingredient (API) development and manufacturing organization. From 1997-2017 Ash Stevens received twelve FDA approvals to manufacture innovator drug substances under his leadership.  These approvals include the oncology drugs bortezomib (Velcade), busulfan (Busulfex), clofarabine (Clolar), and 5- azacitidine (Vidaza), ponatinib (Iclusig) and ixazomib (Ninlaro).  Ash Stevens received six NIH research contracts under his leadership including four competing contract renewals.  Prior to joining Ash Stevens in 1997, Steve worked at Allergan, Inc. initially as a medicinal chemist and subsequently, the co-team leader of the adrenergic drug discovery team.

Steve’s work has been summarized in a number of publications and patents. He is a co-author of the 2016 book - Managing the Drug Discovery Process: How to Make It More Efficient and Cost-Effective. Additionally, he have served as an Adjunct Professor of Chemistry at Wayne State University and on the Henry Ford Community College Biotechnology Advisory Board.  Steve has also served on the Steering Committee of the Chemistry in Cancer Research Working Group of the American Association for Cancer Research (CICR-AACR; 2008-2010; 2011-2013; Chairman, 2014), the Board of Directors of MichBio (2008 - 2014; Chairman 2010 - 2014), the Michigan Biotechnology Innovation Organization (BIO) affiliate. He received his PhD in Organic Chemistry from the University of California, Berkeley.

Photo credit university of michigan

Photo credit university of michigan

William (Bill) Brinkerhoff, MS, MBA

Mr. William (Bill) Brinkerhoff, MS, MBA, served as the President of AlphaCore Pharma LLC until his retirement in 2013. Bill co-founded Cerenis Therapeutics in 2005 and served as its Chief Operating Officer until 2011. He was Vice President of Business Development for Esperion Therapeutics Inc. where he successfully negotiated multiple large potential partnering agreements prior to Esperion's acquisition by Pfizer. Before joining Esperion, Bill was Director of Business Development at Sankyo Co., a Tokyo-based pharmaceutical company. While at Sankyo, he was a member of the Senior Negotiating Team that formed the Sankyo/ Parke-Davis joint venture. Bill has over 20 years of commercial and management experience in the pharmaceutical industry and serves on the board of ONL Therapeutics. He received B.S. and M.S. degrees in Industrial and Operations Engineering and an M.B.A. from the University of Michigan.

 
Photo Credit Pasick Consulting

Photo Credit Pasick Consulting

Robert Pasick, PhD

Dr. Robert Pasick is dedicated to helping individuals and organizations reach their full potential. Since earning his Ph.D. in Clinical Psychology and Public Practice from Harvard University in 1975, Rob has provided leadership development services through teaching, coaching, speaking and writing. He is the President and Founder of Leaders Connect, a leadership development and networking program for executives and entrepreneurs. Included in his past clients are: Ford, Chrysler, Pfizer, Thomson-Reuters, Terumo, Grupo-Antolin, and the University of Michigan. He also is a Adjunct Faculty at the Ross School of Business, University of Michigan. He has made many public appearances on radio and TV. In addition to “Oprah," he has been featured on NBC’s “Today Show,” NPR and CNN.  He often can be heard on radio in Detroit and Ann Arbor. 

Rob’s clients range from Fortune 500 executives from all over the world, to men and women starting their first businesses or stepping into their first professional careers.  Two of his clients won entrepreneur of the year awards in Michigan. His areas of specialty include healthcare, automotive, life science, medical device, higher education, and financial services companies.